Single-Use Negative Pressure Wound Therapy Devices Market Global Report 2028
The single-use negative pressure wound therapy devices market is projected to reach US$ 892.32 million by 2028 from US$ 498.32 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028.
Negative pressure wound therapy (NPWT) is used for managing a wide range of wound types, including traumatic, hard-to-heal, and chronic wounds. It is also used to manage wounds covered with flaps or a skin graft. This therapy is transformed into a medical device such as a single-use NPWT device, which is a small pocket-sized battery-operated device. As the name suggests, these are disposable and portable devices generally used for out-patient care.
The report offers insights and in-depth analysis of the single-use negative pressure wound therapy devices market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The single-use negative pressure wound therapy devices market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in the supply chain and slumped demand due to the lockdown announced by most of the countries worldwide that caused disruptions in manufacturing and operations in the pharmaceutical sector. Additionally, the services for chronic wound care have reduced dramatically in the first and second quarters of 2020 but have normalized at the end of 2020. Furthermore, to reduce cross-contamination through devices, people prefer disposable devices. The increasing use of disposable (single use) NPWT devices is fueling their demand in the global single-use negative pressure wound therapy devices market market. Also, there has been a significant drop in in-patients and out-patients for private hospital chains. To relieve healthcare systems, many clinics have been postponing diagnosis and treatment apart from COVID-19. For instance, in India, the State-run Victoria hospital affiliated with the Bangalore Medical College and Research Institute (BMCRI) was converted into a dedicated COVID-19 facility ever since the pandemic hit Karnataka in March, the functioning of the Mahabodhi Burns Ward in the hospital has not been hit. Despite the pandemic, the hospital continued to operate normally, following all COVID-19 precautions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Single-Use Negative Pressure Wound Therapy Devices Market: Strategic Insights
Single-Use Negative Pressure Wound Therapy Devices Market
-
CAGR (2021 - 2028)
8.8%
-
Market Size 2021
US$ 498.32 Million
-
Market Size 2028
US$ 892.32 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Cardinal Health Inc
- ConvaTec Group Plc
- Carilex Medical
- Genadyne Biotechnologies Inc
- H and R Healthcare
- Lohmann Rauscher GmbH Co KG
- Medela AG
- M lnlycke Health Care AB
- Paul Hartmann Ag
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Wound Type
- Ulcers
- Surgical
- Traumatic
- Sports Injuries
- Flaps and grafts
- Burns
End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Single-Use Negative Pressure Wound Therapy Devices Market: Strategic Insights
-
CAGR (2021 - 2028)8.8% -
Market Size 2021
US$ 498.32 Million -
Market Size 2028
US$ 892.32 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Cardinal Health Inc
- ConvaTec Group Plc
- Carilex Medical
- Genadyne Biotechnologies Inc
- H and R Healthcare
- Lohmann Rauscher GmbH Co KG
- Medela AG
- M lnlycke Health Care AB
- Paul Hartmann Ag
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Ulcers
- Surgical
- Traumatic
- Sports Injuries
- Flaps and grafts
- Burns
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Management of chronic wounds in the pandemic was a very difficult task for both sides – patients and physicians. To minimize the exposure risk during the pandemic, patients used disposable devices rather than conventional NPWT devices. Due to health concerns, people preferred using single-use products to manage chronic and acute wounds. This factor supported the growth of the market during the pandemic situation. The single-use negative pressure wound therapy devices market is segmented into wound type, end user, and geography. The market, based on region, is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
Market Insights
Increase in Cases of Burns
Increase in Cases of Burns
In 2019, a total of 8,378,122 new cases of burns were identified worldwide. Burn fatality rates have been declining in many high-income nations, but child burn deaths are now approximately 7 times greater in low- and middle-income countries than in high-income countries. The single-use negative pressure wound therapy system is used to treat acute and chronic wounds and closed surgical incisions with low to moderate exudate levels. Negative pressure wound therapy (NPWT) involves applying negative pressure (a vacuum) to a wound to manage it and promote healing. Topical negative pressure (TNP) therapy, vacuum aided closure (VAC), and sealed surface wound suction are among the other names for NPWT. NPWT is used to help drain excess fluid and enhance localized blood flow in burn patients. It has been suggested that the action of NPWT may result in increased oxygen and nutrition being delivered to the burn, promoting healing. The single-use negative pressure wound therapy system is for individuals who would benefit from a suction device (negative pressure wound therapy), as it helps promote wound healing by removing low to moderate amounts of exudate and infectious debris. Chronic, acute, traumatic, subacute, and dehisced wounds; partial-thickness burns; ulcers (such as diabetic or pressure); flaps and grafts; closed surgical incisions are all examples of acceptable wound types.
Moreover, according to the Children's Burn Trust and the British Burn Association, 625 children are admitted to an NHS Burns Service each month owing to burn or scald injuries. In 2017, the NHS's burns and scalds services treated more than 15,000 patients with these injuries, with a total cost of more than US$ 24.94 million (i.e., GBP 20 million). More than 40 of the total burn treatment admissions in 2017 were classified as extremely serious, with treatment procedures costing more than US$ 118,455.50 (GBP 95,000) per person. Burns caused by home and industrial mishaps are rising in developing regions such as Asia Pacific, Africa, and the Middle East. Therefore, the market for single-use negative pressure wound care devices is being driven by an increase in the number of occurrences of burns and similar injuries.
Wound Type-Based Insights
The global single-use negative pressure wound therapy devices market, based on wound type, has been segmented into ulcers, surgical, traumatic, sports injuries, flaps and grafts, and burns. In 2022, the traumatic segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. This type of wound is the most common due to the increasing prevalence of road accidents and trauma cases. Moreover, the traumatic segment is expected to register the highest CAGR during 2021–2028.
End User-Based Insights
Based on end user, the single-use negative pressure wound therapy devices market has been segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2022 and is estimated to register the highest CAGR during the forecast period.
The single-use negative pressure wound therapy devices market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand.
Geography-Based Insights
By geography, the single-use negative pressure wound therapy devices market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Single-Use Negative Pressure Wound Therapy Devices Market Report Scope
Report Attribute
Details
Market size in 2021
US$ 498.32 Million
Market Size by 2028
US$ 892.32 Million
Global CAGR (2021 - 2028)
8.8%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Wound Type - Ulcers
- Surgical
- Traumatic
- Sports Injuries
- Flaps and grafts
- Burns
By End User - Hospitals
- Clinics
- Ambulatory Surgical Centers
Regions and Countries Covered
North America - US
- Canada
- Mexico
Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
- Cardinal Health Inc
- ConvaTec Group Plc
- Carilex Medical
- Genadyne Biotechnologies Inc
- H and R Healthcare
- Lohmann Rauscher GmbH Co KG
- Medela AG
- M lnlycke Health Care AB
- Paul Hartmann Ag
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 498.32 Million |
Market Size by 2028 | US$ 892.32 Million |
Global CAGR (2021 - 2028) | 8.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Wound Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Company-Based Insights
Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc are among the leading companies operating in the single-use negative pressure wound therapy devices market.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Wound Type, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russian Federation, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global single-use negative pressure wound therapy devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for single-use negative pressure wound therapy devices market. The presence of top players and favorable regulations related to product approvals coupled with commercialization of new products are the contributing factors to the regional growth. Additionally, the increasing number of technological advancements, the high adoption rate of devices, and increasing prevalence of wounds are the key factor responsible for the Asia-Pacific regional growth for single-use negative pressure wound therapy devices accounting fastest growth of the region during the coming years.
Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag, and Smith & Nephew plc are among the leading companies operating in the global single-use negative pressure wound therapy devices market
The hospital segment dominated the global single-use negative pressure wound therapy devices market and accounted for the largest revenue of 166.73 million in 2021.
Based on wound type, traumatic segment took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.
The increasing prevalence of wounds owing to a surge in trauma, burns, and various conditions such as diabetes and others along with the increase in surgeries are the most significant factors responsible for the overall market growth.
Negative pressure wound therapy (NPWT) is used for managing wide range of wound types such as traumatic, hard-to-heal, and chronic wounds. It is also used to manage wounds that are covered with flaps or a skin graft. This therapy is transformed into a medical device such as a single-use NPWT device, and it is a small pocket-sized battery-operated device. As the name suggests, these are disposable and portable devices generally used for outpatient care.
The List of Companies - Single-Use Negative Pressure Wound Therapy Devices Market
- Cardinal Health Inc
- ConvaTec Group Plc
- Carilex Medical
- Genadyne Biotechnologies, Inc.
- H and R Healthcare
- Lohmann & Rauscher GmbH & Co. KG
- Medela AG
- Mölnlycke Health Care AB
- Paul Hartmann Ag
- Smith & Nephew plc